NCT01321437 Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma Status COMPLETED Phase PHASE2
NCT01320852 PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) Status COMPLETED Phase NA
NCT01320150 Risk Factors and Mechanisms for Persistent Postsurgical Pain After Total Knee Replacement Status COMPLETED Phase N/A
NCT01320085 A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma Status COMPLETED Phase PHASE2
NCT01319656 Integration of Chronic Disease Rehabilitation Services Into Primary Care Status COMPLETED Phase NA
NCT01318031 Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects Status COMPLETED Phase PHASE1
NCT01317134 Endothelial Function in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT01316380 Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma Status COMPLETED Phase PHASE3
NCT01316302 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder Status COMPLETED Phase PHASE4
NCT01314898 A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01314885 Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01313793 A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804 Status COMPLETED Phase PHASE1
NCT01311505 Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) Status COMPLETED Phase PHASE1
NCT01309737 A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01309542 Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01308736 Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit Status COMPLETED Phase NA
NCT01307267 A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab Status COMPLETED Phase PHASE1